Evaluation of Maintaining Visual Performance in Participants Who Engage in Electronic Visual Tasking While Using Restasis®

• Status: Completed
• Trial end date: 2016-03-24
• Target enrollment: 0
• Participant gender: All

Summary

This study will evaluate the efficacy of Restasis® in participants with dry eye disease who engage in electronic visual tasking.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: Cyclosporine; Cyclosporins

Criteria

Inclusion:

• Has Eye Symptoms when using video display terminals

• Has a reported history of dry eye in both eyes.

Exclusion:

• Diagnosed with eye infection or active inflammation.

• Has worn contact lenses within the past 7 days or anticipated use during the study.

• Has used any eye drops within 2 hours.

• Has had laser-assisted in situ keratomileusis (LASIK) within 12 months.

• Has used Restasis® within 90 days.

• Has had any eye and or/lid surgeries within 6 months.

• Has had cataract surgery in either eye.

• Has current punctal occlusion or anticipate a change in punctal occlusion status at any point during the study.

• Is currently taking any topical ophthalmic prescriptions or over-the-counter solutions, artificial tears, gels or lid scrubs that cannot be discontinued for the trial duration.

• Use of medication known to cause ocular drying that is not on a stable dose for at least 30 days.